1.Klevens, RM, Edwards, IR, Richards, CL Jret al.Estimating health care–associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007;122(2):160–166.
2.Roberts, RR, Scott, RD IIHota, B, et al.Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods. Med Care 2010;48(11):1026–1035.
3.Lucado, J, Gould, C, Elixhauser, A. Clostridium difficile infections (CDI) in hospital stays, 2009. Statistical brief 124. Rockville, MD: Healthcare Cost and Utilization Project Statistical Briefs, 2012.
4.Dubberke, ER, Wertheimer, AI. Review of current literature on the economic burden of Clostridium difficile infection. Infect Control Hosp Epidemiol 2009;30(1):57–66.
5.Kyne, L, Hamel, MB, Polavaram, R, Kelly, CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002;34(3):346–353.
6.Dubberke, ER, Butler, AM, Reske, KA, et al.Attributable outcomes of endemic Clostridium difficile–associated disease in nonsurgical patients. Emerg Infect Dis 2008;14(7):1031–1038.
7.Dubberke, ER, Reske, KA, Olsen, MA, McDonald, LC, Fraser, VJ. Short- and long-term attributable costs of Clostridium difficile–associated disease in nonsurgical inpatients. Clin Infect Dis 2008;46(4):497–504.
8.O'Brien, IA, Lahue, BJ, Caro, JJ, Davidson, DM. The emerging infectious challenge of Clostridium difficile–associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol 2007;28(11):1219–1227.
9.Miller, M, Gravel, D, Mulvey, M, et al.Health care–associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 2010;50(2):194–201.
10.Lawrence, SJ, Puzniak, LA, Shadel, BN, Gillespie, KN, Kollef, MH, Mundy, LM. Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure. Infect Control Hosp Epidemiol 2007;28(2):123–130.
11.Kilgore, ML, Ghosh, K, Beavers, CM, Wong, DY, Hymel, PA JrBrossette, SE. The costs of nosocomial infections. Med Care 2008;46(1):101–104.
12.Zilberberg, MD, Tabak, YP, Sievert, DM, et al.Using electronic health information to risk-stratify rates of Clostridium difficile infection in US hospitals. Infect Control Hosp Epidemiol 2011;32(7):649–655.
13.Tabak, YP, Johannes, RS, Silber, JH. Using automated clinical data for risk adjustment: development and validation of six disease-specific mortality predictive models for pay-for-performance. Med Care 2007;45(8):789–805.
14.Tabak, YP, Sun, X, Derby, KG, Kurtz, SG, Johannes, RS. Development and validation of a disease-specific risk adjustment system using automated clinical data. Health Serv Res 2010;45:1815–1835.
16.Parsons, LS, ed. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. In: Proceedings of the 26th Annual SAS Users Group International Conference. Long Beach, CA: SAS Institute, 2001.
17.Austin, PC. Comparing paired vs non-paired statistical methods of analyses when making inferences about absolute risk reductions in propensity-score matched samples. Stat Med 2011;30(11):1292–1301.
18.Rothman, KJ, Greenland, S, Lash, TL. Modern Epidemiology. 3rd ed. Philadelphia: Lippincott-Wolters-Kluwer, 2008.
19.Sato, T. On the variance estimator for the Mantel-Haenszel risk difference. Biometrics 1989;45:1323–1324.
20.Sullivan, LM, Dukes, KA, Losina, E. Tutorial in biostatistics: an introduction to hierarchical linear modelling. Stat Med 1999;18(7):855–888.
21.Efron, B, Tibshirani, R. An Introduction to the Bootstrap. London: Chapman & Hall, 1993.
22.Dubberke, ER, Butler, AM, Yokoe, DS, et al.Multicenter study of surveillance for hospital-onset Clostridium difficile infection by the use of ICD-9-CM diagnosis codes. Infect Control Hosp Epidemiol 2010;31(3):262–268.
23.Dallal, RM, Harbrecht, BG, Boujoukas, AJ, et al.Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 2002;235(3):363–372.
24.Miller, MA, Hyland, M, Ofner-Agostini, M, Gourdeau, M, Ishak, M. Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile–associated diarrhea in Canadian hospitals. Infect Control Hosp Epidemiol 2002;23(3):137–140.
25.Loo, VG, Poirier, L, Miller, MA, et al.A predominantly clonal multi-institutional outbreak of Clostridium difficile–associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353(23):2442–2449.
26.Pepin, J, Valiquette, L, Cossette, B. Mortality attributable to nosocomial Clostridium difficile–associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005;173(9):1037–1042.
27.Forster, AJ, Taljaard, M, Oake, N, Wilson, K, Roth, V, van Walraven, C. The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital. CMAJ 2012;184(1):37–42.
28.Cohen, SH, Gerding, DN, Johnson, S, et al.Clinical practice guide-lines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31(5):431–455.
29.Centers for Disease Control and Prevention. Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep 2012;61(9):157–162.
30.Centers for Medicare and Medicaid Services. Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and FY 2012 rates; hospitals' FTE resident caps for graduate medical education payment. Final rules. Fed Regist 2011;76(160):51476–51843.